Regulatory issues in the era of highly active antiretroviral therapy

AIDS. 2000:14 Suppl 3:S219-25.

Author

J S Murray¹

Affiliation

¹ Division of Antiviral Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA.

PMID: 11086865

No abstract available

Publication types

Review

MeSH terms

Anti-HIV Agents / pharmacokinetics
Anti-HIV Agents / therapeutic use*
Clinical Trials, Phase III as Topic / methods
Clinical Trials, Phase III as Topic / standards
Drug Therapy, Combination
HIV Infections / drug therapy*
Humans
Research Design / standards*
Reverse Transcriptase Inhibitors / pharmacokinetics
Reverse Transcriptase Inhibitors / therapeutic use*
Therapeutic Equivalency

Substances

Anti-HIV Agents
Reverse Transcriptase Inhibitors